Colin Stott
17Patents
12h-index
48Co-inventors
74Inventor score
Filing activity: Dec 17, 2008 → Sep 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9017737B2 | Use of cannabinoids in combination with an anti-psychotic medicament | Human Necessities | 86 | Active |
| US11065227B2 | Use of cannabinoids in the treatment of multiple myeloma | Human Necessities | 34 | Active |
| US8790719B2 | Phytocannabinoids in the treatment of cancer | Human Necessities | 33 | Active |
| US10098867B2 | Use of phytocannabinoids in the treatment of ovarian carcinoma | Human Necessities | 32 | Active |
| US11147776B2 | 7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy | Human Necessities | 28 | Active |
| US11147783B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 26 | Active |
| US9675579B2 | Tetrahydrocannabivarin for use in the treatment of nausea and vomiting | Human Necessities | 25 | Active |
| US9962341B2 | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer | Human Necessities | 21 | Active |
| US10758514B2 | Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour | Human Necessities | 19 | Active |
| US11793770B2 | 7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy | Human Necessities | 15 | Active |
| US11684598B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 14 | Active |
| US9675654B2 | Phytocannabinoids in the treatment of cancer | Human Necessities | 13 | Active |
| US11413266B2 | Use of cannabinoids in the treatment of inflammatory skin diseases | Human Necessities | 12 | Active |
| US10226433B2 | Use of cannabinoids in the treatment of degenerative skeletal muscle diseases | Human Necessities | 12 | Active |
| US10039724B2 | 7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD) | Human Necessities | 12 | Active |
| US9895342B2 | Cannabinoids for use in the treatment of neuropathic pain | Human Necessities | 2 | Active |
| US10258580B2 | Cannabinoids for use in the treatment of neurodegenerative diseases or disorders | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.